MTUS2

Across TCGA pan-cancer cohorts, MTUS2 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated MTUS2 data layer compared with 23 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher MTUS2 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated MTUS2 expression acts as an unfavorable survival marker, although some lineages such as GBM and LSCC show a favorable association.

GBM, PDAC, and LSCC are the cancer types where MTUS2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Tertile	All	0.864	0.551	.005	3	view →
PDAC	OS	Median	IV	0.178	0.905	.038	3	view →
LSCC	DFS	Tertile	All	1.000	0.527	.028	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MTUS2–GBM (DFS)

Open the GBM breakdown →